# CTI BIOPHARMA CORP (CTIC)

> Institutional ownership reported to the SEC as of Q2 2023, from Form 13F filings. Source: https://holderbook.com/stocks/CTIC/

- Reporting holders: 3
- Reported value: $485.2K
- Held through calls: 1.9%
- Held through puts: 0.4%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [UBS ASSET MANAGEMENT AMERICAS INC](https://holderbook.com/funds/861177-ubs-asset-management-americas-inc/) | $389.3K | 92,700 | 0.0% | 3 |
| [Legal & General Group Plc](https://holderbook.com/funds/764068-legal-general-group-plc/) | $84.9K | 9,340 | 0.0% | 5 |
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $11.0K | 0 | 0.0% | 10 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2023 | 3 | $485.2K |
| Q1 2023 | 133 | $482.3M |
| Q4 2022 | 145 | $634.7M |
| Q3 2022 | 127 | $575.1M |
| Q2 2022 | 112 | $519.9M |
| Q1 2022 | 83 | $350.6M |
| Q4 2021 | 56 | $122.4M |
| Q3 2021 | 53 | $160.4M |
| Q2 2021 | 46 | $134.9M |
| Q1 2021 | 51 | $127.1M |
| Q4 2020 | 56 | $142.4M |
| Q3 2020 | 33 | $85.8M |